Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 18.42% is in line with its 5-year average of 19.25%, around the middle of its 5-year range (10.56%–26.80%).
17.51% above its 12-month average of 15.67%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 11.15%.
EBITDA MARGIN
18.42%
EBITDA MARGIN AVG TTM
15.67%
EBITDA MARGIN AVG 3Y
17.52%
EBITDA MARGIN AVG 5Y
19.25%
EBITDA MARGIN AVG 10Y
17.18%
EBITDA MARGIN AVG 15Y
17.07%
EBITDA MARGIN AVG 20Y
16.99%
CURRENT VS TTM AVG
+17.51%
CURRENT VS 3Y AVG
+5.11%
CURRENT VS 5Y AVG
-4.31%
CURRENT VS 10Y AVG
+7.24%
CURRENT VS 15Y AVG
+7.91%
CURRENT VS 20Y AVG
+8.44%
Bio-Rad Laboratories, Inc.
Market Cap
$10.20B
EBITDA Margin
18.42%
TTM Avg
15.67%
3Y Avg
17.52%
5Y Avg
19.25%
Market Cap
$10.15B
EBITDA Margin
20.41%
TTM Avg
18.54%
3Y Avg
20.94%
5Y Avg
21.85%
Market Cap
$10.37B
EBITDA Margin
10.47%
TTM Avg
10.43%
3Y Avg
10.38%
5Y Avg
10.85%
Market Cap
$10.56B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
Market Cap
$10.65B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$10.77B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$10.97B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $10.20B | 18.42% | 15.67% | 17.52% | 19.25% |
| Globus Medical, Inc. (GMED)vs › | $10.15B | 20.41% | 18.54% | 20.94% | 21.85% |
| The Ensign Group, Inc. (ENSG)vs › | $10.37B | 10.47% | 10.43% | 10.38% | 10.85% |
| Henry Schein, Inc. (HSIC)vs › | $9.88B | 8.11% | 8.11% | 8.28% | 8.19% |
| Molina Healthcare, Inc. (MOH)vs › | $10.56B | 2.15% | 3.41% | 4.20% | 4.49% |
| The Cooper Companies, Inc. (COO)vs › | $10.65B | 27.02% | 27.38% | 26.41% | 26.36% |
| Insulet Corp. (PODD)vs › | $9.74B | 21.67% | 20.24% | 16.36% | 15.66% |
| Align Technology, Inc. (ALGN)vs › | $10.77B | 19.75% | 19.29% | 19.87% | 21.06% |
| Universal Health Services, Inc. (UHS)vs › | $10.97B | 15.05% | 14.69% | 13.35% | 14.10% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 28.74% | 23.07% | 27.33% | 30.04% |
Gross Margin
51.9%
EBITDA Margin
18.4%
Operating Margin
9.1%
Net Margin
8.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 11.15% |
| 2026-03-31 | 12.67% |
| 2025-12-31 | 16.49% |
| 2025-09-30 | 18.47% |
| 2025-06-30 | 19.60% |
| 2025-03-31 | 10.56% |
| 2024-12-31 | 16.12% |
| 2024-09-30 | 17.48% |
| 2024-06-30 | 23.20% |
| 2024-03-31 | 16.34% |
| 2023-12-31 | 22.14% |
| 2023-09-30 | 22.00% |
| 2023-06-30 | 21.61% |
| 2023-03-31 | 15.88% |
| 2022-12-31 | 23.11% |
| 2022-09-30 | 18.67% |
| 2022-06-30 | 23.56% |
| 2022-03-31 | 25.68% |
| 2021-12-31 | 19.20% |
| 2021-09-30 | 26.80% |
| 2021-06-30 | 23.51% |
| 2021-03-31 | 19.73% |
| 2020-12-31 | 26.77% |
| 2020-09-30 | 22.12% |
| 2020-06-30 | 16.10% |
| 2020-03-31 | 18.89% |
| 2019-12-31 | 10.02% |
| 2019-09-30 | 18.27% |
| 2019-06-30 | 17.35% |
| 2019-03-31 | 17.97% |
| 2018-12-31 | -32.03% |
| 2018-09-30 | 13.05% |
| 2018-06-30 | 13.56% |
| 2018-03-31 | 14.14% |
| 2017-12-31 | 14.46% |
| 2017-09-30 | 15.28% |
| 2017-06-30 | 6.87% |
| 2017-03-31 | 11.84% |
| 2016-12-31 | 1.68% |
| 2016-09-30 | 13.09% |
| 2016-06-30 | 11.63% |
| 2016-03-31 | 12.69% |
| 2015-12-31 | 16.36% |
| 2015-09-30 | 14.09% |
| 2015-06-30 | 14.29% |
| 2015-03-31 | 14.09% |
| 2014-12-31 | 15.10% |
| 2014-09-30 | 13.26% |
| 2014-06-30 | 15.28% |
| 2014-03-31 | 11.22% |
| 2013-12-31 | 15.65% |
| 2013-09-30 | 13.07% |
| 2013-06-30 | 16.46% |
| 2013-03-31 | 13.38% |
| 2012-12-31 | 18.78% |
| 2012-09-30 | 19.32% |
| 2012-06-30 | 20.56% |
| 2012-03-31 | 17.57% |
| 2011-12-31 | 21.59% |
| 2011-09-30 | 20.19% |
| 2011-06-30 | 18.75% |
| 2011-03-31 | 19.63% |
| 2010-12-31 | 20.00% |
| 2010-09-30 | 21.45% |
| 2010-06-30 | 20.16% |
| 2010-03-31 | 19.99% |
| 2009-12-31 | 11.37% |
| 2009-09-30 | 20.30% |
| 2009-06-30 | 19.04% |
| 2009-03-31 | 18.40% |
| 2008-12-31 | 10.06% |
| 2008-09-30 | 17.24% |
| 2008-06-30 | 18.85% |
| 2008-03-31 | 17.40% |
| 2007-12-31 | 10.23% |
| 2007-09-30 | 15.33% |
| 2007-06-30 | 14.79% |
| 2007-03-31 | 16.50% |
| 2006-12-31 | 11.88% |
| 2006-09-30 | 14.34% |
| 2006-06-30 | 17.84% |
| 2006-03-31 | 19.57% |
| 2005-12-31 | 12.47% |
| 2005-09-30 | 14.08% |
| 2005-06-30 | 14.71% |
| 2005-03-31 | 18.47% |
| 2004-12-31 | 14.65% |
| 2004-09-30 | 10.11% |
| 2004-06-30 | 17.77% |
| 2004-03-31 | 17.50% |
| 2003-12-31 | 16.72% |
| 2003-09-30 | 17.74% |
| 2003-06-30 | 18.58% |
| 2003-03-31 | 21.98% |
| 2002-12-31 | 18.10% |
| 2002-09-30 | 20.33% |
